Triple
T9812303
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | aflibercept |
E238303
|
entity |
| Predicate | targets |
P860
|
FINISHED |
| Object |
vascular endothelial growth factor A
Vascular endothelial growth factor A (VEGF-A) is a key signaling protein that promotes the growth of new blood vessels and increases vascular permeability, playing a central role in angiogenesis and various diseases such as cancer and eye disorders.
|
E823216
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: vascular endothelial growth factor A | Statement: [aflibercept, targets, vascular endothelial growth factor A]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: vascular endothelial growth factor A Context triple: [aflibercept, targets, vascular endothelial growth factor A]
-
A.
platelet-derived growth factor
Platelet-derived growth factor is a key signaling protein that regulates cell growth, proliferation, and angiogenesis, and plays important roles in wound healing and various pathological conditions such as cancer and fibrosis.
-
B.
aflibercept
Aflibercept is an anti-VEGF biologic drug used primarily to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
-
C.
Activase
Activase is a brand-name form of the clot-dissolving drug alteplase, widely used as a thrombolytic treatment for acute ischemic stroke and certain types of heart attack and pulmonary embolism.
-
D.
EGF
EGF is the ICAO airline designator used to identify American Eagle Airlines in aviation operations and communications.
-
E.
IN-2
IN-2 is the standard postal-style abbreviation used to refer to Indiana's 2nd congressional district in the U.S. House of Representatives.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: vascular endothelial growth factor A Triple: [aflibercept, targets, vascular endothelial growth factor A]
Generated description
Vascular endothelial growth factor A (VEGF-A) is a key signaling protein that promotes the growth of new blood vessels and increases vascular permeability, playing a central role in angiogenesis and various diseases such as cancer and eye disorders.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: vascular endothelial growth factor A Target entity description: Vascular endothelial growth factor A (VEGF-A) is a key signaling protein that promotes the growth of new blood vessels and increases vascular permeability, playing a central role in angiogenesis and various diseases such as cancer and eye disorders.
-
A.
platelet-derived growth factor
Platelet-derived growth factor is a key signaling protein that regulates cell growth, proliferation, and angiogenesis, and plays important roles in wound healing and various pathological conditions such as cancer and fibrosis.
-
B.
aflibercept
Aflibercept is an anti-VEGF biologic drug used primarily to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
-
C.
Activase
Activase is a brand-name form of the clot-dissolving drug alteplase, widely used as a thrombolytic treatment for acute ischemic stroke and certain types of heart attack and pulmonary embolism.
-
D.
EGF
EGF is the ICAO airline designator used to identify American Eagle Airlines in aviation operations and communications.
-
E.
IN-2
IN-2 is the standard postal-style abbreviation used to refer to Indiana's 2nd congressional district in the U.S. House of Representatives.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ca84defac48190abc1148804f184c1 |
completed | March 30, 2026, 2:12 p.m. |
| NER | Named-entity recognition | batch_69cdb222ba788190a9085272a3de7852 |
completed | April 2, 2026, 12:02 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d1cc63c450819091e57030a48e7d88 |
completed | April 5, 2026, 2:43 a.m. |
| NEDg | Description generation | batch_69d1cce3d9d481909eaf7278dfe20955 |
completed | April 5, 2026, 2:45 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69d1cd5d1670819085c58ff8889318af |
completed | April 5, 2026, 2:47 a.m. |
Created at: March 30, 2026, 8:30 p.m.